Related Experiment Video
Updated: May 31, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
A multidisciplinary cancer center maximizes surgeons' impact
Christy L Marshall1, Courtney J Balentine, Celia N Robinson
1Department of Surgery, The Michael E. DeBakey Veterans' Affairs Medical Center, Houston, Texas, USA.
The Journal of Surgical Research
|June 24, 2011
Summary
Establishing a dedicated colorectal cancer center (CRCC) improves multidisciplinary care and patient outcomes. Specialty surgeons enhance surgical care, but a multidisciplinary center is key for integrated treatment and better results.
Area of Science:
- Oncology
- Surgical Oncology
- Health Services Research
Background:
- Colorectal cancer (CRC) necessitates integrated care across multiple disciplines for optimal outcomes.
- Multidisciplinary management is crucial for achieving excellent oncologic results in CRC patients.
- The establishment of a dedicated colorectal cancer center (CRCC) was hypothesized to enhance multidisciplinary care and patient outcomes.
Purpose of the Study:
- To evaluate the impact of establishing a dedicated colorectal cancer center (CRCC) on multidisciplinary management and oncologic outcomes.
- To assess the role of specialty-trained surgeons and a CRCC in improving colorectal cancer care.
Main Methods:
- Analysis of data from three distinct periods: baseline, post-specialty surgeon recruitment, and post-CRCC establishment.
- Evaluation of surrogate markers for surgical oncologic care, including multidisciplinary integration and oncologic outcomes.
- Comparative analysis to determine the effects of specialized surgeons versus a dedicated multidisciplinary center.
Main Results:
- Recruitment of specialty-trained surgeons demonstrated improvements in surgical oncologic care.
- Establishment of the CRCC led to further enhancements in surgical oncologic care.
- The CRCC significantly improved multidisciplinary integration and oncologic outcomes.
Conclusions:
- While specialty surgeons improve surgical care, a dedicated multidisciplinary center is essential for truly integrated care.
- The establishment of a CRCC is pivotal for improving oncologic outcomes in colorectal cancer patients.
- Integrated care models, centered around multidisciplinary teams, are critical for advancing colorectal cancer treatment.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...